Clover Health CFO Joseph Wagner to step down Aug 13; Mark Herbers named interim CFO

CLOVER HEALTH INVESTMENTS, CORP. /DE

CFO Joseph Wagner departs Aug 13, 2021 for personal reasons; no disagreement with company.
Mark Herbers of AlixPartners appointed interim CFO effective Aug 13; permanent search underway.
Lee Shapiro (Audit Committee Chair) leads search committee; executive search firm engaged.
Wagner cites family health challenges; says decision not related to company operations or policies.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Mark Herbers

Interim Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2021-08-13
Filed: July 15, 2021, 7:59 PM ET

Effective upon the Departure Date, and until a permanent replacement for Mr. Wagner has been named, Mark Herbers will serve as the Company’s interim Chief Financial Officer.

Departed

Joseph Wagner

Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2021-08-13
Successor: Mark Herbers
Filed: July 15, 2021, 7:59 PM ET

On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, will be stepping down as an officer of the Company on August 13, 2021 (the “Departure Date”), following the filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Second Quarter 2021 Form 10-Q”), for personal reasons.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Herbers was appointed as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

Effective upon the Departure Date, and until a permanent replacement for Mr. Wagner has been named, Mark Herbers will serve as the Company’s interim Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph Wagner departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: stepping down
Role: Chief Financial Officer

Exact text from the filing

On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, will be stepping down as an officer of the Company on August 13, 2021 (the “Departure Date”), following the filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 (the “Second Quarter 2021 Form 10-Q”), for personal reasons.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001193125-21-215904

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.